Pseudomonas aeruginosa ventricular assist device infections: findings from ineffective phage therapies in five cases.
Aslam S, Roach D, Nikolich MP, Biswas B, Schooley RT, Lilly-Bishop KA, Rice GK, Cer RZ, Hamilton T, Henry M, Luong T, Salabarria A-C, Sisk-Hackworth L, Filippov AA, Lebreton F, Hall L, Nir-Paz R, Onallah H, Livni G, Shostak E, Wieder-Finesod A, Yahav D, Yerushalmy O, Alkalay-Oren S, Braunstein R, Khalifa L, Rimon A, Gelman D, Hazan R.
Aslam S, et al.
Antimicrob Agents Chemother. 2024 Apr 3;68(4):e0172823. doi: 10.1128/aac.01728-23. Epub 2024 Mar 12.
Antimicrob Agents Chemother. 2024.
PMID: 38470133
Free PMC article.
We assessed phage susceptibility, bacterial strain sequencing, serum neutralization, biofilm activity, and shelf-life of phage preparations. Five treatments of one to four wild-type virulent phage(s) were administered for 14-51 days after informed consent and regulatory ap …
We assessed phage susceptibility, bacterial strain sequencing, serum neutralization, biofilm activity, and shelf-life of phage preparations. …